Skip to main content
OpenTrials

Clinical trial condition

Transitional Cell Cancer of the Renal Pelvis and Ureter

Explore clinical trials studying Transitional Cell Cancer of the Renal Pelvis and Ureter. Study availability and eligibility vary by location and protocol.

32 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Transitional Cell Cancer of the Renal Pelvis and Ureter trial results

Recruiting

Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

NCT06124976

Conditions
Transitional Cell Cancer of the Renal Pelvis and Ureter, Urothelial Carcinoma of the Renal Pelvis and Ureter
Locations
  • Vancouver Prostate Centre Vancouver, British Columbia, Canada
  • Men's Health Clinic Winnipeg, Manitoba, Canada
  • Centre of Applied Urology Research, Nova Scotia Health Authority Halifax, Nova Scotia, Canada
  • UHN - Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium

NCT00053209

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
  • Porter Adventist Hospital Denver, Colorado, United States
View all 121 locations
View Trial Details
Completed

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

NCT00003376

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
View all 50 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

NCT00005644

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
  • CCOP - Kalamazoo Kalamazoo, Michigan, United States
  • Veterans Affairs Medical Center - East Orange East Orange, New Jersey, United States
  • James P. Wilmot Cancer Center Rochester, New York, United States
View all 16 locations
View Trial Details
Completed

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

NCT00002914

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Emory University Hospital - Atlanta Atlanta, Georgia, United States
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States
View all 29 locations
View Trial Details
Completed

Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer

NCT00004223

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 76 locations
View Trial Details
Completed

Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract

NCT00006111

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Institut Sainte Catherine Avignon, France
  • Centre Oscar Lambret Lille, France
  • Centre Leon Berard Lyon, France
  • Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France
View Trial Details
Completed

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

NCT01191892

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom
  • Wales Cancer Trials Unit Cardiff, Wales, United Kingdom
  • Ayr Hospital Ayr, United Kingdom
  • Royal Bournemouth General Hospital Bournemouth, United Kingdom
View all 21 locations
View Trial Details
Completed

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

NCT01089088

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, Avon, United Kingdom
  • Castle Hill Hospital Cottingham, East Yorkshire, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, England, United Kingdom
  • Churchill Hospital Oxford, Oxfordshire, United Kingdom
View all 16 locations
View Trial Details
Completed

Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

NCT00310011

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States
  • Regional Cancer Center Greensboro, North Carolina, United States
  • Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
View Trial Details

Related conditions